浙江医药
(600216)
| 流通市值：138.57亿 | | | 总市值：138.57亿 |
| 流通股本：9.62亿 | | | 总股本：9.62亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,217,402,229.72 | 1,965,821,411.06 | 1,635,716,620.56 | 1,468,842,479.23 |
| 应收票据及应收账款 | 1,709,971,371.66 | 1,627,259,114.94 | 1,690,337,783.45 | 1,395,634,148.29 |
| 应收账款 | 1,709,971,371.66 | 1,627,259,114.94 | 1,690,337,783.45 | 1,395,634,148.29 |
| 应收款项融资 | 256,144,390.43 | 203,184,865.67 | 214,570,975.78 | 258,418,548.86 |
| 预付款项 | 125,731,474.67 | 87,739,818.34 | 122,750,233.14 | 120,818,624.79 |
| 其他应收款合计 | 76,074,129.6 | 194,790,405.14 | 134,880,569.14 | 97,759,927.31 |
| 存货 | 2,039,510,754.71 | 2,132,515,095.23 | 1,945,483,588.92 | 1,907,058,263.75 |
| 其他流动资产 | 96,408,402.79 | 78,723,872.42 | 74,762,702.54 | 65,491,411.92 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 6,811,951,484.56 | 6,584,941,036.57 | 6,146,702,104.36 | 5,669,917,652.8 |
| 非流动资产: | | | | |
| 长期股权投资 | 74,404,761.76 | 86,057,742.62 | 77,135,930.71 | 78,766,319.95 |
| 其他非流动金融资产 | 69,898,612.81 | 70,456,197.95 | 73,457,421.71 | 75,313,059.21 |
| 投资性房地产 | 88,618,680.34 | 91,903,446.1 | 92,602,361.5 | 93,301,276.9 |
| 固定资产 | 5,235,410,630.53 | 5,115,672,097.19 | 4,965,911,138.13 | 4,859,572,739.77 |
| 在建工程 | 838,058,122.21 | 982,504,818.13 | 1,193,715,133.97 | 1,211,242,597.43 |
| 使用权资产 | 23,073,019.8 | 23,031,122.48 | 23,429,029.82 | 23,048,873.01 |
| 无形资产 | 664,010,125.77 | 684,403,126.75 | 698,669,085.79 | 709,420,707.29 |
| 商誉 | - | - | 18,680,361.98 | 18,680,361.98 |
| 长期待摊费用 | 11,721,955.98 | 12,811,381.1 | 12,441,031.93 | 4,920,163.5 |
| 递延所得税资产 | 139,395,643.21 | 124,936,448.56 | 84,475,322.15 | 78,988,211.47 |
| 其他非流动资产 | 40,110,360.66 | 18,755,688.24 | 42,293,191.26 | 54,707,324.96 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 7,184,701,913.07 | 7,210,532,069.12 | 7,282,810,008.95 | 7,207,961,635.47 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 13,996,653,397.63 | 13,795,473,105.69 | 13,429,512,113.31 | 12,877,879,288.27 |
| 流动负债: | | | | |
| 短期借款 | 270,268,100 | 270,281,100 | 235,226,300 | 235,226,300 |
| 应付票据及应付账款 | 1,067,318,313.8 | 1,129,780,215.13 | 1,173,478,371.54 | 1,116,600,491.58 |
| 其中：应付票据 | 63,398,732.25 | 51,224,143.42 | 29,010,297.6 | 27,932,262.17 |
| 应付账款 | 1,003,919,581.55 | 1,078,556,071.71 | 1,144,468,073.94 | 1,088,668,229.41 |
| 合同负债 | 38,577,151.05 | 29,307,795.18 | 45,685,386.54 | 43,465,220.07 |
| 应付职工薪酬 | 88,987,455.5 | 213,868,771.41 | 137,629,829.37 | 100,631,093.94 |
| 应交税费 | 182,750,235.12 | 268,257,678.29 | 211,927,001.35 | 73,373,270.39 |
| 其他应付款合计 | 355,135,205.01 | 347,746,959.62 | 408,797,933.37 | 414,880,752.35 |
| 应付股利 | 29,971.18 | 29,971.18 | 29,971.18 | 2,014,859 |
| 一年内到期的非流动负债 | 379,999,957.21 | 306,855,610.49 | 141,662,765.84 | 141,450,793.58 |
| 其他流动负债 | 3,897,350.59 | 3,346,320.31 | 3,737,452.76 | 4,192,258.31 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 2,386,933,768.28 | 2,569,444,450.43 | 2,358,145,040.77 | 2,129,820,180.22 |
| 非流动负债: | | | | |
| 长期借款 | 146,129,600 | 171,149,400 | 372,307,500 | 424,357,700 |
| 租赁负债 | 302,337.31 | 144,726.57 | 534,489.41 | 162,328.39 |
| 预计负债 | 81,737,851.46 | 82,197,123.46 | - | - |
| 递延收益 | 115,583,535.74 | 104,595,165.33 | 89,123,759.93 | 78,782,534.68 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 343,753,324.51 | 358,086,415.36 | 461,965,749.34 | 503,302,563.07 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 2,730,687,092.79 | 2,927,530,865.79 | 2,820,110,790.11 | 2,633,122,743.29 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 961,637,750 | 961,637,750 | 961,637,750 | 961,637,750 |
| 资本公积 | 1,989,734,541.59 | 1,987,727,152.01 | 1,987,669,645.8 | 1,986,020,084.21 |
| 其他综合收益 | 7,206,420.34 | -1,360,564.68 | 4,383,624.88 | 1,781,332.61 |
| 盈余公积 | 1,766,915,160.58 | 1,766,915,160.58 | 1,647,513,860.84 | 1,647,513,860.84 |
| 未分配利润 | 6,342,307,879.21 | 5,933,222,587.15 | 5,740,096,409.49 | 5,350,022,271.85 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 11,067,801,751.72 | 10,648,142,085.06 | 10,341,301,291.01 | 9,946,975,299.51 |
| 少数股东权益 | 198,164,553.12 | 219,800,154.84 | 268,100,032.19 | 297,781,245.47 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 11,265,966,304.84 | 10,867,942,239.9 | 10,609,401,323.2 | 10,244,756,544.98 |
| 负债和股东权益合计 | 13,996,653,397.63 | 13,795,473,105.69 | 13,429,512,113.31 | 12,877,879,288.27 |
| 公告日期 | 2025-04-24 | 2025-04-24 | 2024-10-25 | 2024-08-23 |
| 审计意见(境内) | | 标准无保留意见 | | |